HeidiAnnMcKeanMD
Oncology • Sioux Falls, SDGastrointestinal Cancer, Genitourinary Oncology, Thoracic Cancer
Medical oncologist
Dr. McKean is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 E. 23rd St.
Ste. 230
Sioux Falls, SD 57105Phone+1 605-322-6900Fax+1 605-322-6901
Summary
- Dr. Heidi McKean is an oncologist in Sioux Falls, SD and is affiliated with multiple hospitals in the area, including Avera McKennan Hospital and University Health Center and Avera St. Mary's Hospital. She received her medical degree from Sanford School of Medicine of the University of South Dakota and has been in practice 12 years. She specializes in medical oncology and is experienced in pancreatic cancer, colorectal cancer, malignant melanoma, non-small cell lung carcinoma, small-cell lung carcinoma, renal cell carcinoma and brain tumors.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2008 - 2011- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2005 - 2008
University of South Dakota, Sanford School of MedicineClass of 2005
Certifications & Licensure
IA State Medical License 2011 - 2027
MN State Medical License 2006 - 2025
SD State Medical License Active through 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012
Publications & Presentations
PubMed
- 19 citationsUGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine.Matthew P. Goetz, Heidi McKean, Joel M. Reid, Sumithra J. Mandrekar, Angelina D. Tan
Investigational New Drugs. 2013-10-10 - 2 citationsSafety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, ...Daniel J George, David R Spigel, Lucio N Gordan, Samith T Kochuparambil, Ana M Molina
BMJ Open. 2022-09-14 - 4 citationsEvaluating Symptom Distress in Cancer Patients.Vanessa Wookey, Heidi McKean
South Dakota Medicine. 2016-05-01
Press Mentions
Avera’s Commitment to Rural Health Displayed in Cancer CareNovember 20th, 2024
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
